Hepatitis C Virus
Researchers describe findings in hepatitis C virus studies
Published in Gastroenterology Week, April 10th, 2006
Study 1: According to recently published research from Italy, activation of V gamma 9V delta 2 T cells by non-peptidic antigens induces the inhibition of subgenomic hepatitis C virus (HCV) replication.
"HCV has evolved complex strategies to evade host immune responses and establish chronic infection. Since human V gamma 9V delta 2 T lymphocytes play a critical role in the immune response against viruses, we analyzed their antiviral functions on Huh7 hepatoma cells carrying the subgenomic HCV replicon (Rep60 cells)," wrote C. Agrati and colleagues, National...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Acid Reflux
Rabeprazole may be a valuable step-down therapy for gastroesophageal reflux disease - Antimicrobial Agents
Intra-abdominal infections treated with moxifloxacin monotherapy - Gastric Cancer
Disseminated peritoneal scirrhous gastric cancer is responsive to gene-drug therapy - Nephroblastoma
Wilms tumor complicated by liver metastases linked to less favorable outcome - Peptic Stenosis
Scintigraphy utilizing Tc-99m is an effective method to assess improvement in gastric function - Adverse Drug Reaction
ICH codes alone are not helpful in evaluating adverse drug reactions - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
